168 related articles for article (PubMed ID: 21348892)
1. The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma.
Kunii R; Jiang S; Hasegawa G; Yamamoto T; Umezu H; Watanabe T; Tsuchida M; Hashimoto T; Hamakubo T; Kodama T; Sasai K; Naito M
Histopathology; 2011 Feb; 58(3):467-76. PubMed ID: 21348892
[TBL] [Abstract][Full Text] [Related]
2. GATA6-positive lung adenocarcinomas are associated with invasive mucinous adenocarcinoma morphology, hepatocyte nuclear factor 4α expression, and KRAS mutations.
Nakajima N; Yoshizawa A; Nakajima T; Hirata M; Furuhata A; Sumiyoshi S; Rokutan-Kurata M; Sonobe M; Menju T; Miyamoto E; Chen-Yoshikawa TF; Date H; Haga H
Histopathology; 2018 Jul; 73(1):38-48. PubMed ID: 29469192
[TBL] [Abstract][Full Text] [Related]
3. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
[TBL] [Abstract][Full Text] [Related]
4. Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.
Matsubara D; Soda M; Yoshimoto T; Amano Y; Sakuma Y; Yamato A; Ueno T; Kojima S; Shibano T; Hosono Y; Kawazu M; Yamashita Y; Endo S; Hagiwara K; Fukayama M; Takahashi T; Mano H; Niki T
Cancer Sci; 2017 Sep; 108(9):1888-1896. PubMed ID: 28677170
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma].
Zu Y; Wang X; Liu X; Chen Y; Li C; Shang X; Xie Y; Zhao H; Wang J
Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):131-7. PubMed ID: 23514941
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
[TBL] [Abstract][Full Text] [Related]
7. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.
Sugano M; Nagasaka T; Sasaki E; Murakami Y; Hosoda W; Hida T; Mitsudomi T; Yatabe Y
Am J Surg Pathol; 2013 Feb; 37(2):211-8. PubMed ID: 23108025
[TBL] [Abstract][Full Text] [Related]
8. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.
Kadota K; Nitadori J; Sarkaria IS; Sima CS; Jia X; Yoshizawa A; Rusch VW; Travis WD; Adusumilli PS
Cancer; 2013 Mar; 119(5):931-8. PubMed ID: 23096929
[TBL] [Abstract][Full Text] [Related]
9. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
[TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer.
Zu YF; Wang XC; Chen Y; Wang JY; Liu X; Li X; Li CW; Xie YC; Luo Y; Shang XQ; Guo J
Oncol Rep; 2012 Nov; 28(5):1544-50. PubMed ID: 22940844
[TBL] [Abstract][Full Text] [Related]
11. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T
Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371
[TBL] [Abstract][Full Text] [Related]
12. Thyroid transcription factor-1 in primary CNS tumors.
Kristensen MH; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):437-43. PubMed ID: 21325940
[TBL] [Abstract][Full Text] [Related]
13. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines.
Fujita J; Ohtsuki Y; Bandoh S; Ueda Y; Kubo A; Tojo Y; Yamaji Y; Ishida T
Lung Cancer; 2003 Jan; 39(1):31-6. PubMed ID: 12499091
[TBL] [Abstract][Full Text] [Related]
14. The mouse Muc5b mucin gene is transcriptionally regulated by thyroid transcription factor-1 (TTF-1) and GATA-6 transcription factors.
Jonckheere N; Velghe A; Ducourouble MP; Copin MC; Renes IB; Van Seuningen I
FEBS J; 2011 Jan; 278(2):282-94. PubMed ID: 21126317
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
16. MUC5AC, cytokeratin 20 and HER2 expression and K-RAS mutations within mucinogenic growth in congenital pulmonary airway malformations.
Rossi G; Gasser B; Sartori G; Migaldi M; Costantini M; Mengoli MC; Piccioli S; Cavazza A; Rivasi F
Histopathology; 2012 Jun; 60(7):1133-43. PubMed ID: 22348416
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF
Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718
[TBL] [Abstract][Full Text] [Related]
18. TTF-1 expression in pulmonary adenocarcinomas.
Yatabe Y; Mitsudomi T; Takahashi T
Am J Surg Pathol; 2002 Jun; 26(6):767-73. PubMed ID: 12023581
[TBL] [Abstract][Full Text] [Related]
19. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
[TBL] [Abstract][Full Text] [Related]
20. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]